Sintx Technologies(SINT) Newsfilter·2024-12-17 11:00Core Insights - SINTX Technologies has received a Notice of Allowance from the USPTO for its patent application titled "Methods of Silicon Nitride Laser Cladding," highlighting its leadership in biomaterial innovation and strengthening its intellectual property portfolio [1][5] - The patent protects a novel method for laser bonding bioactive silicon nitride to various biomedical implant substrates, enhancing their biological performance through superior osseointegration and bacterial resistance [2][3] - SINTX is the only FDA-registered producer of implantable silicon nitride, with a focus on expanding its technology applications across diverse markets [4][5] Intellectual Property and Innovation - The company now holds 17 issued U.S. patents and 84 pending patent applications globally, reinforcing its position as a leader in advanced ceramics and biomaterial innovation [5] - The newly allowed patent complements a recently granted U.S. Patent (US 12162807), expanding SINTX's capabilities in enhancing traditional implantable device materials [3] Market Position and Strategy - SINTX's advancements in silicon nitride technology open new opportunities in the biomedical field and provide innovative pathways for upgrading existing medical devices [3][4] - The company has been involved in strategic acquisitions and alliances to enter new markets, with manufacturing and R&D facilities located in Utah and Maryland [6]